PRESS RELEASE published on 12/10/2024 at 20:29, 1 year 7 months ago LIGHTON announces the end of the stabilization period, the full exercice of the over-allotment option and the implementation of a liquidity contract. LightOn announces the end of the stabilization period, full exercise of the over-allotment option, and implementation of a liquidity contract following its IPO on Euronext Growth® Paris market Liquidity Contract Euronext Growth LightOn Over-allotment Option Stabilization Period
BRIEF published on 11/26/2024 at 18:57, 1 year 8 months ago Roquette Concludes EUR 1.2 Billion Bond Offering Acquisition Bond Offering Roquette IFF Pharma Solutions Pharmaceutical Excipients
BRIEF published on 11/26/2024 at 18:57, 1 year 8 months ago Roquette conclut une émission obligataire de 1,2 milliard d'euros Acquisition Roquette Offre D'obligations Solutions Pharmaceutiques IFF Excipients Pharmaceutiques
PRESS RELEASE published on 11/26/2024 at 18:52, 1 year 8 months ago PRESS RELEASE - BOND EMISSION CLOSING Roquette completes successful EUR 1.2bn bond offering for transformative acquisition of IFF Pharma Solutions. Strong investor demand reflects confidence in Roquette's strategy and expansion plans Expansion Investor Demand Bond Offering Roquette IFF Pharma Solutions
BRIEF published on 11/21/2024 at 17:57, 1 year 8 months ago LightOn réussit son introduction en bourse sur Euronext Growth Paris Euronext Growth Bourse IA Générative LightOn Introduction
BRIEF published on 11/21/2024 at 17:57, 1 year 8 months ago LightOn successfully completes its IPO on Euronext Growth Paris Generative AI Euronext Growth Sotck Exchange LightOn Introduction
PRESS RELEASE published on 11/21/2024 at 17:52, 1 year 8 months ago LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris. LightOn annonce son introduction en bourse avec succès sur Euronext Growth® Paris, 1ère dans l'IA générative en Europe. Augmentation de capital à 11,9 M€. Négociations le 26 novembre 2024 IA Générative Introduction En Bourse Sursouscription Euronext Growth® Paris LightOn
PRESS RELEASE published on 11/21/2024 at 17:52, 1 year 8 months ago LIGHTON announces highly successful IPO on Euronext Growth Paris. LightOn successfully completes IPO on Euronext Growth® Paris, raising €11.9m with strong demand. Market capitalization at €62m before Over-allotment Option. Trading to start on 26 November 2024 Generative AI IPO Market Capitalization Euronext Growth® Paris LightOn
BRIEF published on 11/20/2024 at 08:15, 1 year 8 months ago Crédit Agricole Assurances Successfully Sells Française des Jeux Shares Investment Strategy Institutional Investors Share Sale Française Des Jeux Crédit Agricole Assurances
BRIEF published on 11/20/2024 at 08:15, 1 year 8 months ago Crédit Agricole Assurances cède avec succès les actions de la Française des Jeux Investisseurs Institutionnels Stratégie D'investissement Vente D'actions Crédit Agricole Assurances Français Des Jeux
Published on 08/07/2026 at 23:15, 2 days 8 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 8 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 2 days 8 hours ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 2 days 9 hours ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/10/2026 at 07:00, 17 minutes ago Infracore SA announces partial exercise of the over-allotment option
Published on 08/10/2026 at 07:00, 17 minutes ago Infracore SA annonce l’exercice partiel de l’option de surallocation
Published on 08/10/2026 at 07:00, 17 minutes ago MindMaze Therapeutics Completes Organizational Simplification and Provides Update on Neuro.io Equity Financing
Published on 08/10/2026 at 07:00, 17 minutes ago ARYZTA protects profitability in a demanding environment; Capital returns to resume in 2027; Reviewing all options for Germany
Published on 08/10/2026 at 07:00, 17 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 17 minutes ago Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
Published on 08/07/2026 at 18:54, 2 days 12 hours ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 2 days 12 hours ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 2 days 12 hours ago Disclosure of transactions in own shares from August 3 to August 7, 2026
